Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul W Finn

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Scientific Reports|October 13, 2025
Novel antimicrobial 3-phenyl-4-phenoxypyrazole derivatives target cell wall lipid intermediates with low mammalian cytotoxicityBlanca Fernandez-Ciruelos, Marco Albanese, Femke Taverne, et al.
Journal of Molecular Graphics & Modelling|October 6, 2009
Molecular similarity including chiralityM Stuart Armstrong, Garrett M Morris, Paul W Finn, et al.
Journal of Chemical Information and Modeling|February 19, 2013
Molecular determinants of binding to the Plasmodium subtilisin-like protease 1Simone Fulle, Chrislaine Withers-Martinez, Michael J Blackman, et al.
Journal of Chemical Information and Modeling|May 24, 2019
Ligity: A Non-Superpositional, Knowledge-Based Approach to Virtual ScreeningJean-Paul Ebejer, Paul W Finn, Wing Ki Wong, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2014
Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1Samir S Kher, Maria Penzo, Simone Fulle, et al.
Molecules (Basel, Switzerland)|October 14, 2014
Exploration of piperidinols as potential antitubercular agentsAreej Abuhammad, Elizabeth Fullam, Sanjib Bhakta, et al.
Journal of Computer-Aided Molecular Design|July 9, 2010
ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostaticsM Stuart Armstrong, Garrett M Morris, Paul W Finn, et al.
Molecular Cancer Therapeutics|August 27, 2003
Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101Jane A Plumb, Paul W Finn, Robert J Williams, et al.
Microbiology Spectrum|June 25, 2024
Repurposing Hsp90 inhibitors as antimicrobials targeting two-component systems identifies compounds leading to loss of bacterial membrane integrityBlanca Fernandez-Ciruelos, Marco Albanese, Anmol Adhav, et al.
The Biochemical Journal|September 18, 2007
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitorsNagma Khan, Michael Jeffers, Sampath Kumar, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|October 13, 2025
Novel antimicrobial 3-phenyl-4-phenoxypyrazole derivatives target cell wall lipid intermediates with low mammalian cytotoxicityBlanca Fernandez-Ciruelos, Marco Albanese, Femke Taverne, et al.
Journal of Molecular Graphics & Modelling|October 6, 2009
Molecular similarity including chiralityM Stuart Armstrong, Garrett M Morris, Paul W Finn, et al.
Journal of Chemical Information and Modeling|February 19, 2013
Molecular determinants of binding to the Plasmodium subtilisin-like protease 1Simone Fulle, Chrislaine Withers-Martinez, Michael J Blackman, et al.
Journal of Chemical Information and Modeling|May 24, 2019
Ligity: A Non-Superpositional, Knowledge-Based Approach to Virtual ScreeningJean-Paul Ebejer, Paul W Finn, Wing Ki Wong, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2014
Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1Samir S Kher, Maria Penzo, Simone Fulle, et al.
Molecules (Basel, Switzerland)|October 14, 2014
Exploration of piperidinols as potential antitubercular agentsAreej Abuhammad, Elizabeth Fullam, Sanjib Bhakta, et al.
Journal of Computer-Aided Molecular Design|July 9, 2010
ElectroShape: fast molecular similarity calculations incorporating shape, chirality and electrostaticsM Stuart Armstrong, Garrett M Morris, Paul W Finn, et al.
Molecular Cancer Therapeutics|August 27, 2003
Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101Jane A Plumb, Paul W Finn, Robert J Williams, et al.
Microbiology Spectrum|June 25, 2024
Repurposing Hsp90 inhibitors as antimicrobials targeting two-component systems identifies compounds leading to loss of bacterial membrane integrityBlanca Fernandez-Ciruelos, Marco Albanese, Anmol Adhav, et al.
The Biochemical Journal|September 18, 2007
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitorsNagma Khan, Michael Jeffers, Sampath Kumar, et al.
Pageof 3